These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 6762567)

  • 1. Membrane transport of anthracyclines.
    Skovsgaard T; Nissen NI
    Pharmacol Ther; 1982; 18(3):293-311. PubMed ID: 6762567
    [No Abstract]   [Full Text] [Related]  

  • 2. A new antitumor antibiotic, carminomycin (NSC-180024).
    Gause GF; Brazhnikova MG; Shorin VA
    Cancer Chemother Rep; 1974; 58(2):255-6. PubMed ID: 4830498
    [No Abstract]   [Full Text] [Related]  

  • 3. Modes of resistance to anthracyclines and other natural products.
    Kessel D; Romine M; Decker D
    Prog Clin Biol Res; 1986; 223():81-93. PubMed ID: 3543948
    [No Abstract]   [Full Text] [Related]  

  • 4. Interactions among membrane transport systems: anthracyclines, calcium antagonists and anti-estrogens.
    Kessel D
    Biochem Pharmacol; 1986 Aug; 35(16):2825-6. PubMed ID: 2943288
    [No Abstract]   [Full Text] [Related]  

  • 5. Cellular transport of anthracyclines by passive diffusion. Implications for drug resistance.
    Siegfried JM; Burke TG; Tritton TR
    Biochem Pharmacol; 1985 Mar; 34(5):593-8. PubMed ID: 3856430
    [No Abstract]   [Full Text] [Related]  

  • 6. Rodorubicin, a new tetraglycosidic anthracycline.
    Kraemer HP; Sedlacek HH
    Behring Inst Mitt; 1988 Apr; (82):216-30. PubMed ID: 3165634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Some antineoplastic antibiotics.
    Cheng CC; Zee-Cheng KY
    J Pharm Sci; 1972 Apr; 61(4):485-501. PubMed ID: 4111335
    [No Abstract]   [Full Text] [Related]  

  • 8. Relationship between the intracellular accumulation of anthracyclines and effectiveness in vitro and in vivo.
    Tapiero H; Munck JN; Fourcade A
    Drugs Exp Clin Res; 1986; 12(1-3):257-64. PubMed ID: 3460752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanism of resistance to anthracyclines and vinca alkaloids.
    Danø K; Skovsgaard T; Nissen NI; Friche E; Di Marco A
    Prog Clin Biol Res; 1983; 132C():231-46. PubMed ID: 6579564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Arugomycin, a new anthracycline antibiotic. III. Biological activities of arugomycin and its analogues obtained by chemical degradation and modification.
    Shimosaka A; Kawai H; Hayakawa Y; Komeshima N; Nakagawa M; Seto H; Otake N
    J Antibiot (Tokyo); 1987 Sep; 40(9):1283-91. PubMed ID: 3479414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The anthracycline antineoplastic drugs.
    Young RC; Ozols RF; Myers CE
    N Engl J Med; 1981 Jul; 305(3):139-53. PubMed ID: 7017406
    [No Abstract]   [Full Text] [Related]  

  • 12. Facile exchange of the cyano group in highly potent anticancer cyanomorpholinyl anthracyclines.
    Peters JH; Gordon GR; Nolen HW; Tracy M; Thomas DW
    Biochem Pharmacol; 1988 Jan; 37(2):357-61. PubMed ID: 3422560
    [No Abstract]   [Full Text] [Related]  

  • 13. Experimental evaluation of anthracycline analogs.
    Casazza AM
    Cancer Treat Rep; 1979 May; 63(5):835-44. PubMed ID: 455325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New anthracycline antibiotic aclacinomycin A: experimental studies and correlations with clinical trials.
    Oki T; Takeuchi T; Oka S; Umezawa H
    Recent Results Cancer Res; 1981; 76():21-40. PubMed ID: 6940212
    [No Abstract]   [Full Text] [Related]  

  • 15. Cytofluorescence localization of anthracycline antibiotics.
    Egorin MJ; Clawson RE; Cohen JL; Ross LA; Bachur NR
    Cancer Res; 1980 Dec; 40(12):4669-76. PubMed ID: 6934029
    [No Abstract]   [Full Text] [Related]  

  • 16. Circumvention of resistance to anthracyclines by calcium antagonists and other membrane-perturbing agents.
    Kessel D
    Cancer Surv; 1986; 5(1):109-27. PubMed ID: 3297311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [New anthracycline antibiotics taurimycins A and B produced by a Str. tauricus No. 7036-1 culture].
    Frolova VI; Kuzovkov AD; Rozynov BV; Taĭg MM; Ivanitskaia LP
    Antibiotiki; 1982 May; 27(5):326-31. PubMed ID: 6954874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical assessment of the structure-activity relationship of anthracyclines and related synthetic derivatives.
    Young CW; Raymond V
    Cancer Treat Rep; 1986 Jan; 70(1):51-63. PubMed ID: 2935251
    [No Abstract]   [Full Text] [Related]  

  • 19. Biological studies on formycin and formycin B.
    Ishizuka M; Sawa T; Hori S; Takayama H; Takeuchi T
    J Antibiot (Tokyo); 1968 Jan; 21(1):5-12. PubMed ID: 5673295
    [No Abstract]   [Full Text] [Related]  

  • 20. New anthracycline derivatives from betaclamycin A.
    Yoshimoto A; Matsuzawa Y; Ishikura T; Sawa T; Takeuchi T; Umezawa H
    J Antibiot (Tokyo); 1984 Aug; 37(8):920-2. PubMed ID: 6480506
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.